Access

Article

Nature 407, 870-876 (19 October 2000) | doi:10.1038/35038011; Received 6 July 2000; Accepted 30 August 2000

Open Innovation Challenges

naturejobs

Vasoregulation by the bold beta1 subunit of the calcium-activated potassium channel

Robert Brenner1, Guillermo J. Peréz2, Adrian D. Bonev2, Delrae M. Eckman2, Jon C. Kosek3, Steven W. Wiler1, Andrew J. Patterson4, Mark T. Nelson2 & Richard W. Aldrich1

  1. Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
  2. Department of Pharmacology, College of Medicine, The University of Vermont, Burlington, Vermont 05405, USA
  3. Department of Pathology, Palo Alto Veterans Administration Healthcare System, Palo Alto, California 94305 and Stanford University School of Medicine , Stanford, California 94305, USA
  4. Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305, USA

Correspondence to: Richard W. Aldrich1 Correspondence and requests for materials should be addressed to R.W.A. (e-mail: Email: raldrich@leland.stanford.edu).

Top

Small arteries exhibit tone, a partially contracted state that is an important determinant of blood pressure. In arterial smooth muscle cells, intracellular calcium paradoxically controls both contraction and relaxation. The mechanisms by which calcium can differentially regulate diverse physiological responses within a single cell remain unresolved. Calcium-dependent relaxation is mediated by local calcium release from the sarcoplasmic reticulum. These 'calcium sparks' activate calcium-dependent potassium (BK) channels comprised of alpha and beta1 subunits. Here we show that targeted deletion of the gene for the beta1 subunit leads to a decrease in the calcium sensitivity of BK channels, a reduction in functional coupling of calcium sparks to BK channel activation, and increases in arterial tone and blood pressure. The beta1 subunit of the BK channel, by tuning the channel's calcium sensitivity, is a key molecular component in translating calcium signals to the central physiological function of vasoregulation.

  1. Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
  2. Department of Pharmacology, College of Medicine, The University of Vermont, Burlington, Vermont 05405, USA
  3. Department of Pathology, Palo Alto Veterans Administration Healthcare System, Palo Alto, California 94305 and Stanford University School of Medicine , Stanford, California 94305, USA
  4. Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305, USA

Correspondence to: Richard W. Aldrich1 Correspondence and requests for materials should be addressed to R.W.A. (e-mail: Email: raldrich@leland.stanford.edu).